Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew C Hooker

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Annals of Biomedical Engineering|February 8, 2003
An evaluation of population D-optimal designs via pharmacokinetic simulationsAndrew C Hooker, Marco Foracchia, Michael G Dodds, et al.
The AAPS Journal|February 9, 2011
Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects modelsMartin Bergstrand, Andrew C Hooker, Johan E Wallin, et al.
The AAPS Journal|July 4, 2020
Saddle-Reset for Robust Parameter Estimation and Identifiability Analysis of Nonlinear Mixed Effects ModelsHenrik Bjugård Nyberg, Andrew C Hooker, Robert J Bauer, et al.
The AAPS Journal|July 16, 2011
Optimal design in population kinetic experiments by set-valued methodsPeter Gennemark, Alexander Danis, Joakim Nyberg, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 26, 2009
Optimization of the intravenous glucose tolerance test in T2DM patients using optimal experimental designHanna E Silber, Joakim Nyberg, Andrew C Hooker, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 14, 2014
Optimal clinical trial design based on a dichotomous Markov-chain mixed-effect sleep modelC Steven Ernest, Joakim Nyberg, Mats O Karlsson, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 10, 2023
Optimizing the design of a pharmacokinetic trial to evaluate the dosing scheme of a novel tuberculosis drug in children living with or without HIVGrace Montepiedra, Elin M Svensson, Weng Kee Wong, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 15, 2012
Serial correlation in optimal design for nonlinear mixed effects modelsJoakim Nyberg, Richard Höglund, Martin Bergstrand, et al.
The AAPS Journal|March 12, 2009
Modeling subpopulations with the $MIXTURE subroutine in NONMEM: finding the individual probability of belonging to a subpopulation for the use in model analysis and improved decision makingKristin C Carlsson, Radojka M Savić, Andrew C Hooker, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 28, 2013
Optimizing disease progression study designs for drug effect discriminationSebastian Ueckert, Stefanie Hennig, Joakim Nyberg, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Annals of Biomedical Engineering|February 8, 2003
An evaluation of population D-optimal designs via pharmacokinetic simulationsAndrew C Hooker, Marco Foracchia, Michael G Dodds, et al.
The AAPS Journal|February 9, 2011
Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects modelsMartin Bergstrand, Andrew C Hooker, Johan E Wallin, et al.
The AAPS Journal|July 4, 2020
Saddle-Reset for Robust Parameter Estimation and Identifiability Analysis of Nonlinear Mixed Effects ModelsHenrik Bjugård Nyberg, Andrew C Hooker, Robert J Bauer, et al.
The AAPS Journal|July 16, 2011
Optimal design in population kinetic experiments by set-valued methodsPeter Gennemark, Alexander Danis, Joakim Nyberg, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 26, 2009
Optimization of the intravenous glucose tolerance test in T2DM patients using optimal experimental designHanna E Silber, Joakim Nyberg, Andrew C Hooker, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 14, 2014
Optimal clinical trial design based on a dichotomous Markov-chain mixed-effect sleep modelC Steven Ernest, Joakim Nyberg, Mats O Karlsson, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 10, 2023
Optimizing the design of a pharmacokinetic trial to evaluate the dosing scheme of a novel tuberculosis drug in children living with or without HIVGrace Montepiedra, Elin M Svensson, Weng Kee Wong, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 15, 2012
Serial correlation in optimal design for nonlinear mixed effects modelsJoakim Nyberg, Richard Höglund, Martin Bergstrand, et al.
The AAPS Journal|March 12, 2009
Modeling subpopulations with the $MIXTURE subroutine in NONMEM: finding the individual probability of belonging to a subpopulation for the use in model analysis and improved decision makingKristin C Carlsson, Radojka M Savić, Andrew C Hooker, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 28, 2013
Optimizing disease progression study designs for drug effect discriminationSebastian Ueckert, Stefanie Hennig, Joakim Nyberg, et al.
Pageof 8